The Second Generation of Cholinesterase Inhibitors: Clinical and Pharmacological Effects

This publication has 89 references indexed in Scilit:

• Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease
  Neuroscience Letters, 1991
• Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis
  Acta Neurologica Scandinavica, 1990
• Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial
  Drug Development Research, 1990
• Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase
  Neuroscience Letters, 1989
• Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects
  Drug Development Research, 1988
• Efficacy of oral physostigmine in primary degenerative dementia
  Psychopharmacology, 1985
• Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in alzheimer's disease
  Neuroscience, 1985
• Effect of Cholinergic and Anticholinergic Drugs on Short-Term Memory in Alzheimerʼs Dementia
  Clinical Neuropharmacology, 1983
• Physostigmine and its effect on six patients with dementia
  American Journal of Psychiatry, 1981
• DETERMINATION OF THE NUMBER, DISTRIBUTION, AND SOME IN SITU PROPERTIES OF CHOLINESTERASE MOLECULES IN THE MOTOR END PLATE, USING LABELED INHIBITOR METHODS
  Annals of the New York Academy of Sciences, 1967